Other languages Ono Pharmaceutical Co., Ltd.

Equities

4528

JP3197600004

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
2,300 ^JPY	+1.34%		+2.77%	-8.59%

Mar. 21	ONO Pharmaceuticals, Co., Ltd. Announces Enrollment is Complete for the First Arm of the PROSPECT Study of Tirabrutinib in U.S. Patients with Relapsed or Refractory PCNSL	CI
Mar. 14	Sibylla Biotech Enters Strategic Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd. in Central Nervous System Disorders	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ONO Pharmaceuticals, Co., Ltd. Announces Enrollment is Complete for the First Arm of the PROSPECT Study of Tirabrutinib in U.S. Patients with Relapsed or Refractory PCNSL	Mar. 21
Sibylla Biotech Enters Strategic Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd. in Central Nervous System Disorders	Mar. 14
Ono Pharmaceutical Co., Ltd. Enters into A University-Wide, Research Alliance Agreement with Harvard University	Mar. 11
InveniAI LLC Announces Collaboration with Ono Pharmaceutical for Target Discovery	Feb. 19
Shattuck Labs Collaborates With Ono Pharmaceutical to Develop Fusion Proteins	Feb. 14
Ono Pharmaceutical Co., Ltd. Enters into Collaboration Agreement with EVQLV to Generate Novel Antibodies against Multiple Targets Utilizing EVQLV's AI-powered Antibody Design Engine for Development of Innovative Antibody Drugs	Dec. 21
Ono Enters into Research Collaboration with UK Dementia Research Institute	Dec. 21
Biomed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research	Dec. 19
Turbine Simulated Cell Technologies Ltd. Establishes Research Collaboration with Ono Pharmaceutical Co., Ltd. to Identify and Validate Novel Oncology Targets	23-10-24
Ono Pharmaceutical Co., Ltd. Enters into A Drug Discovery Collaboration Agreement with Adimab to Discover Novel Antibody Drugs in the Oncology Field	23-09-27
Ono Pharmaceutical Co., Ltd. announces an Equity Buyback for 19,000,000 shares, representing 3.89% for ¥50,000 million.	23-07-24
Ono Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	23-07-24
El Nikkei cae un 0,5% arrastrado por los valores electrónicos y farmacéuticos -- Market Talk	23-06-27
Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer	23-05-16
El Nikkei cae un 0,4%, arrastrado por las farmacéuticas y las siderúrgicas -- Market Talk	23-05-10
Ono Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-09
Macomics Ltd and Ono Pharmaceutical Co., Ltd. Partner to Discover and Develop Macrophage-Targeting Antibody Therapy for the Treatment of Cancer	23-03-23
Ono Enters into A Drug Discovery Collaboration Agreement with Peptidream to Discover and Develop Macrocyclic Constrained Peptide Therapeutics	23-03-13
Nuevas compras en la cartera Inversor Asia	23-02-24
Nouveaux achats dans le portefeuille Investisseur Asie	23-02-24

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Ono Pharmaceutical Co., Ltd.

Equities

4528

JP3197600004

Other languages

Filters